Related references
Note: Only part of the references are listed.Immunophenotypic and genomic characterization of papillary carcinomas of the breast
Raphaelle Duprez et al.
JOURNAL OF PATHOLOGY (2012)
Adenoid cystic carcinomas constitute a genomically distinct subgroup of triple-negative and basal-like breast cancers
Daniel Wetterskog et al.
JOURNAL OF PATHOLOGY (2012)
Challenges translating breast cancer gene signatures into the clinic
Britta Weigelt et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
PIK3CA mutations rarely demonstrate genotypic intratumoral heterogeneity and are selected for in breast cancer progression
Kevin Kalinsky et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
LOXL2-Mediated Matrix Remodeling in Metastasis and Mammary Gland Involution
Holly E. Barker et al.
CANCER RESEARCH (2011)
Genetic Interactions in Cancer Progression and Treatment
Alan Ashworth et al.
CELL (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Breast Cancer 2 Gene expression profiling in breast cancer: classification, prognostication, and prediction
Jorge S. Reis-Filho et al.
LANCET (2011)
Tumour evolution inferred by single-cell sequencing
Nicholas Navin et al.
NATURE (2011)
Molecular differences between ductal carcinoma in situ and adjacent invasive breast carcinoma: a multiplex ligation-dependent probe amplification study
Cathy B. Moelans et al.
CELLULAR ONCOLOGY (2011)
The microenvironment in breast cancer progression: biology and implications for treatment
Andrew E. Place et al.
BREAST CANCER RESEARCH (2011)
Phosphatidylinositol-3-kinase and AKT1 mutations occur early in breast carcinoma
Jennifer Dunlap et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
How Darwinian models inform therapeutic failure initiated by clonal heterogeneity in cancer medicine
M. Gerlinger et al.
BRITISH JOURNAL OF CANCER (2010)
PIK3CA Mutations in In situ and Invasive Breast Carcinomas
Alexander Miron et al.
CANCER RESEARCH (2010)
Inferring tumor progression from genomic heterogeneity
Nicholas Navin et al.
GENOME RESEARCH (2010)
Breast cancer precursors revisited: molecular features and progression pathways
Maria A. Lopez-Garcia et al.
HISTOPATHOLOGY (2010)
Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotype
So Yeon Park et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Molecular analysis reveals a genetic basis for the phenotypic diversity of metaplastic breast carcinomas
Felipe C. Geyer et al.
JOURNAL OF PATHOLOGY (2010)
Mucinous carcinoma of the breast is genomically distinct from invasive ductal carcinomas of no special type
Magali Lacroix-Triki et al.
JOURNAL OF PATHOLOGY (2010)
Genome remodelling in a basal-like breast cancer metastasis and xenograft
Li Ding et al.
NATURE (2010)
Expression of miR-21 and its targets (PTEN, PDCD4, TM1) in flat epithelial atypia of the breast in relation to ductal carcinoma in situ and invasive carcinoma
Liqiang Qi et al.
BMC CANCER (2009)
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
Kandice R. Levental et al.
CELL (2009)
Phosphoinositide 3-Kinase Mutations in Breast Cancer: A Good Activating Mutation?
Serena Di Cosimo et al.
CLINICAL CANCER RESEARCH (2009)
Tiling Path Genomic Profiling of Grade 3 Invasive Ductal Breast Cancers
Rachael Natrajan et al.
CLINICAL CANCER RESEARCH (2009)
Mixed micropapillary-ductal carcinomas of the breast: a genomic and immunohistochemical analysis of morphologically distinct components
Caterina Marchio et al.
JOURNAL OF PATHOLOGY (2009)
Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution
Sohrab P. Shah et al.
NATURE (2009)
Regulation of in situ to invasive breast carcinoma transition
Min Hu et al.
CANCER CELL (2008)
Integrated genomic and transcriptomic analysis of ductal carcinoma in situ of the breast
Anne Vincent-Salomon et al.
CLINICAL CANCER RESEARCH (2008)
Ductal carcinoma in situ and the emergence of diversity during breast cancer evolution
D. Craig Allred et al.
CLINICAL CANCER RESEARCH (2008)
Screening for copy-number alterations and loss of heterozygosity in chronic lymphocytic leukemia -: A comparative study of four differently designed, high resolution Microarray platforms
Rebeqa Gunnarsson et al.
GENES CHROMOSOMES & CANCER (2008)
Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients
David S. P. Tan et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Breast cancer progression: insights into multifaceted matrix metalloproteinases
Vincent Chabottaux et al.
CLINICAL & EXPERIMENTAL METASTASIS (2007)
Getting it right: designing microarray (and not 'microawry') comparative genomic hybridization studies for cancer research
David S. P. Tan et al.
LABORATORY INVESTIGATION (2007)
Chromogenic and fluorescent in situ hybridization in breast cancer
Maryou B. K. Lambros et al.
HUMAN PATHOLOGY (2007)
Resolving the resolution of array CGH
Bradley P. Coe et al.
GENOMICS (2007)
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer
Antonio C. Wolff et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
HER2 status in pure ductal carcinoma in situ and in the intraductal and invasive components of invasive ductal carcinoma determined by fluorescence in situ hybridization and immunohistochemistry
K Park et al.
HISTOPATHOLOGY (2006)
Combined cDNA array comparative genomic hybridization and serial analysis of gene expression analysis of breast tumor progression
J Yao et al.
CANCER RESEARCH (2006)
Unlocking pathology archives for molecular genetic studies:: a reliable method to generate probes for chromogenic and fluorescent in situ hybridization
MBK Lambros et al.
LABORATORY INVESTIGATION (2006)
Distinct epigenetic changes in the stromal cells of breast cancers
M Hu et al.
NATURE GENETICS (2005)
Do myoepithelial cells hold the key for breast tumor progression?
K Polyak et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2005)
The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up
ME Sanders et al.
CANCER (2005)
Medical progress - Ductal carcinoma in situ of the breast
HJ Burstein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Patterns of chromosomal alterations in breast ductal carcinoma in situ
ES Hwang et al.
CLINICAL CANCER RESEARCH (2004)
Association of C-MYC amplification with progression from the in situ to the invasive stage in C-MYC-amplified breast carcinomas
EC Robanus-Maandag et al.
JOURNAL OF PATHOLOGY (2003)
Gene expression profiles of human breast cancer progression
XJ Ma et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
The role of HER2/neu overexpression/amplification in the progression of ductal carcinoma in situ to invasive carcinoma of the breast
EK Latta et al.
MODERN PATHOLOGY (2002)
MCF10DCIS.com xenograft model of human comedo ductal carcinoma in situ
FR Miller et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
